Table 3. Hazard ratios (95% CI) of cancer incidence, all-cause death, cancer death, and noncancer death by MET-min/week in women^a .

	MET-min/week				≥3.5 vs 0 MET-min/week
	0	3.5–1000	>1000	P for trend
	(n = 20 481)	(n = 3889)	(n = 3602)
Cancer incidence
Cases	1139	211	193
Rateb	6.7	6.7	6.7
Model 1	1.0	0.93 (0.79–1.10)	1.02 (0.86–1.20)	0.5831	0.97 (0.86–1.10)
Model 2	1.0	0.94 (0.77–1.13)	0.99 (0.81–1.19)	0.3085	0.96 (0.83–1.11)
All-cause death
Cases	630	81	66
Rateb	5.0	3.2	4.4
Model 1	1.0	0.60 (0.46–0.77)	0.71 (0.54–0.93)	<0.0001	0.65 (0.53–0.79)
Model 2	1.0	0.59 (0.44–0.79)	0.78 (0.58–1.04)	<0.0001	0.67 (0.54–0.83)
Cancer death
Cases	235	27	38
Rateb	1.6	1.1	1.5
Model 1	1.0	0.62 (0.41–0.92)	1.07 (0.76–1.52)	0.1892	0.82 (0.62–1.08)
Model 2	1.0	0.62 (0.40–0.97)	1.17 (0.80–1.69)	0.3829	0.86 (0.64–1.17)
Noncancer death
Cases	395	54	28
Rateb	3.4	2.1	2.9
Model 1	1.0	0.58 (0.41–0.82)	0.44 (0.28–0.69)	<0.0001	0.52 (0.39–0.69)
Model 2	1.0	0.56 (0.38–0.84)	0.47 (0.29–0.78)	<0.0001	0.52 (0.38–0.72)

^aAdjusted for age, smoking status, alcohol intake, body mass index, hypertension, total cholesterol, and diabetes.

^bAge-adjusted rate (per 100 000 person years).

Model 1: Without exclusion of early cases (those occurring within 3 years of the starting point).

Model 2: After exclusion of early cases (those occurring within 3 years of the starting point).